Stocktoria
Canton Strategic Holdings, Inc. CNTN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-01-12
Chart by TradingView
3/9
Piotroski F — financial health
2.91
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$20.1M | -$12.4M | -$9.5M | -$6.9M | -$3.2M |
| Net income | -$35.9M | -$12.2M | -$9.3M | -$8.5M | -$2.2M |
| Operating cash flow | -$16.1M | -$10.9M | -$7.3M | -$6.6M | -$1.1M |
| Total assets | $519.1M | $3.7M | $10.9M | $6.7M | $621,677 |
| Total liabilities | $121.2M | $2.4M | $1.8M | $1.1M | $5.3M |
| Shareholders' equity | $397.9M | $1.3M | $9.1M | $5.5M | -$4.7M |
| Ratios | |||||
| Return on assets | -6.9% | -327.7% | -85.1% | -126.7% | -355.0% |
| Return on equity | -9.0% | -932.8% | -102.1% | -152.8% | 47.1% |
| Current ratio | 5.29 | 1.54 | 6.03 | 5.84 | 0.14 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| ARK Investment Management LLC | 3,695,084 | $12.1M |
| RENAISSANCE TECHNOLOGIES LLC | 562,000 | $1.8M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.91 (safe)
- Working capital / assets 0.027
- Retained earnings / assets -0.14
- EBIT / assets -0.039
- Equity / liabilities 3.283
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001861657 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.